Cited by 147Thyroid Disorders and TreatmentsEnzyme Structure and FunctionProtein Structure and Dynamics

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 12 of the 27 sources its claims cite were checked for support.

The structure of human thyroglobulin

Open access

Abstract

Thyroglobulin (TG) is the protein precursor of thyroid hormones, which are essential for growth, development and the control of metabolism in vertebrates1,2. Hormone synthesis from TG occurs in the thyroid gland via the iodination and coupling of pairs of tyrosines, and is completed by TG proteolysis3. Tyrosine proximity within TG is thought to enable the coupling reaction but hormonogenic tyrosines have not been clearly identified, and the lack of a three-dimensional structure of TG has prevented mechanistic understanding4. Here we present the structure of full-length human thyroglobulin at a resolution of approximately 3.5 Å, determined by cryo-electron microscopy. We identified all of the hormonogenic tyrosine pairs in the structure, and verified them using site-directed mutagenesis and in vitro hormone-production assays using human TG expressed in HEK293T cells. Our analysis revealed that the proximity, flexibility and solvent exposure of the tyrosines are the key characteristics of hormonogenic sites. We transferred the reaction sites from TG to an engineered tyrosine donor–acceptor pair in the unrelated bacterial maltose-binding protein (MBP), which yielded hormone production with an efficiency comparable to that of TG. Our study provides a framework to further understand the production and regulation of thyroid hormones. The cryo-electron microscopy structure of human thyroglobulin reveals that proximity, flexibility and solvent exposure are key characteristics of its hormonogenic tyrosine pairs, and provides a framework for understanding the formation of thyroid hormones.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

The paper reports the cryo-EM structure of full-length human thyroglobulin at ~3.5 Å and identifies/validates its four hormonogenic sites and five donor tyrosines. It shows that proximity, flexibility, solvent exposure, and roughly antiparallel orientation enable T4 synthesis, and transfers a functional hormonogenic site into engineered maltose binding protein.

Key findings

  • The human thyroglobulin dimer structure was determined at ~3.5 Å resolution (eTG C2 map 3.39 Å; rTG expanded map 3.67 Å), with a bilobed shape of 120 × 235 Å, a dimer interface of 29,350 Ų, and an atomic model covering 93% of 2,749 amino acids (2,569 protein residues; PDB 6SCJ).
  • Four hormonogenic acceptor tyrosines were identified—Y24 (Site A), Y2573 (Site B), Y2766 (Site C), and Y1310 (Site D)—with five donor tyrosines: Y234 and Y149 for Site A, Y2540 for Site B, Y2766 for Site C, and Y108 for Site D. Mutating all acceptors abolished T4 synthesis; mutating all five donors gave no significant T4 formation, and Site A was confirmed to have two donors.
  • TG synthesises seven T4 molecules per dimer: two each of Sites A, B, and D, and one Site C. Key requirements for hormonogenesis are solvent exposure, proximity, roughly antiparallel orientation, and high mobility; a conserved acidic residue precedes the acceptor, and D1309 was essential for Site D while K1415 was not.
  • An engineered MBP variant with a C-terminal SGSDYS insert (C-ins2) produced T4 at levels comparable to a single TG site. Crosslinking mass spectrometry validated the architecture, no inter-subunit disulfides were found, and 12 previously predicted N-linked GlcNAc plus four new sites (N110, N484, N1869, N2122) were resolved; glycan N2013 mediates NTD–CTD contact.

Methods

  • Recombinant full-length human TG was expressed in HEK293T cells; endogenous TG was purified from goitrous human thyroid glands. Cryo-EM used a Titan Krios G2 with K2 Summit detector, C2 and symmetry-expanded refinements, and model building combined de novo and homology modelling.
  • Site-directed mutagenesis replaced acceptor or donor tyrosines with phenylalanines. In vitro iodination used KI, glucose/glucose oxidase, and lactoperoxidase or thyroid peroxidase; T4 and T3 were measured by commercial ELISA. MBP variants were engineered and assayed similarly.
  • Cryo-EM datasets: eTG 422,087 initial and 181,830 final particles; rTG 240,194 initial and 151,601 final particles. Crosslinking mass spectrometry used BS3, tryptic digestion, SEC enrichment, and LC-MS/MS with Xi search at 2% residue-pair FDR.

Limitations

  • Stated: map resolution is non-uniform, with central ChEL regions at ~3 Å but peripheral Arm regions at ~6 Å; the model has variable local quality. The NTD is partially flexible, Y24 is partially disordered, residues 24–29 were built tentatively as poly-alanine, and Y2766 was not resolved in the maps. Only T4, not T3, was detected under the in vitro conditions.
  • Stated: endogenous TG was partly iodinated and partially degraded; recombinant TG was non-iodinated. The in vitro assay relies on LPO/TPO and ELISA detection rather than the native thyroid environment.
  • Evident from the text: the atomic model covers 93% of the 2,749 amino acids, leaving some regions unmodelled; side-chain placements at hormonogenic sites are difficult due to conformational disorder; and the MBP engineering test is limited to a small set of designed variants.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-1995-4

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

54 Own result · 17 Own interpretation · 15 Own method · 10 No full text of the sources · 9 No basis given · 5 Partly supported · 4 Supported · 1 Supported so far · 1 Couldn’t confirm · accuracy not yet measured

Show all 62 claims

  • Probably not a substantial claim. 21
  • It may state two separate claims as one. 39
54 of 54
  • The paper relies on this without support.

    Mutating a tyrosine to phenylalanine completely abolishes its ability to act as a hormonogenic donor or acceptor.

    “rTG variants where acceptor or donor tyrosines were mutated to phenylalanines, abolishing hormone formation”
  • The paper relies on this without support.

    The four TG hormonogenic sites contribute independently to total T4 production, so their individual activities can be summed.

    “the sum of the concentrations measured individually recapitulates the total T4 amount produced by unmodified rTG”
  • The paper relies on this without support.

    The in vitro LPO/TPO iodination assay reproduces the hormonogenic reaction of TG in vivo.

    “TH synthesis was performed by rTG in vitro iodination, and the T4 or T3 concentrations were measured by adapting a commercial ELISA assay”
  • The paper relies on this without support.

    TG has 3-4 hormonogenic sites.

    “Considering that TG has 3-4 sites, 0.1 μM was determined to be the optimal starting concentration for the assay.”
4 of 4

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 49 references

Cited by

Sorted by citations

Items 101–147 of 147

Metadata

Authors
Coscia, F., Taler-Verčič, A., Chang, V. T., Sinn, L., O’Reilly, F. J., Izoré, T., Renko, M., Berger, I., Rappsilber, J., Turk, D., & Löwe, J.
Affiliations
  • MRC Laboratory of Molecular Biology (GB)
  • Technische Universität Berlin (DE)
  • Jožef Stefan Institute (SI)
  • University of Bristol (GB)
  • Wellcome Centre for Cell Biology (GB)
Corresponding author
  • Turk, Dušan
  • Löwe, Jan
Venue
Nature
Published
2020-02-05
Volume
578
Issue
7796
Pages
627-630
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3004797639
Cited by
147
References
49
Citations by year
2026: 21 · 2025: 14 · 2024: 32 · 2023: 29 · 2022: 22 · 2021: 22 · 2020: 7
FWCI
15.01
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, other-oa)
  • Bristol Research (University of Bristol) (publishedVersion, other-oa)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Explore Bristol Research (submittedVersion, other-oa)
Funders
Wellcome Trust (103139, 103139/Z/13/Z, 202754/Z/16/Z, 202754, 203149)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords
thyroglobulin, thyroid hormones, hormone biosynthesis, protein structure, solvent exposure, maltose-binding protein, site-directed mutagenesis
MeSH terms
Bacterial Proteins, Humans, Models, Molecular, Mutation, Solvents, Thyroglobulin, Thyroid Hormones, Tyrosine, Reproducibility of Results, Cryoelectron Microscopy, HEK293 Cells, Maltose-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review